Neva Net
The first and only integrated microfiltration technology. NeVa Net devices incorporate a unique braided mesh within the distal end of the expandable tip.
The next frontier in thrombectomy.
The first and only integrated microfiltration technology designed to maximize clot retention.
STUDY A
STUDY B
Superior first pass success*
STUDY A
Successful first pass recanalization: percentage of eTICI 2B-3 in the CLEAR study (mITT, n = 107)
STUDY B
Excellent first pass recanalization: percentage of eTICI 2C-3 in the CLEAR study (mITT, n = 107)
* Core-lab adjudicated results from FDA-regulated IDE study NeVa CLEAR presented by Yoo A, et al. abstract 4311, ISC, Feb. 2023
Highly efficacy design agnostic to clot morphology*
* Results from in-vitro simulated thrombectomy studies: Machi P, et al. Journal of Neuroradiology. April 2018. Results from animal model study: Ulm A.J. et al. Interventional Neurology 2018 ; 7 :205-2017
STUDY A
SUCCESSFUL IN REMOVING ALL CLOT TYPES.
Neva recanalization rates in different clot morphologies.
Results from animal model study: Ulm A.J. et al. Interventional Neurology 2018; 7 :205-2017
STUDY B
SUCCESSFUL WHERE OTHER DEVICES FAIL.
Success rate of stent retrievers when interaction with large white thrombi (≥6 mm).
Results from in-vitro simulated thrombectomy studies: Machi P, et al. JNIS. 2016; 0:1–7 and Machi P, et al. Journal of Neuroradiology. April 2018
STUDY A
STUDY B
ALL TESTED DEVICES FAILED:
0%
NEVA SUCCEEDED:
60%
STUDY A
STUDY B
Proven safety*
* Results from FDA-regulated IDE study NeVa CLEAR presented by Yoo A, et al. abstract 4311, ISC, Feb. 2023.
STUDY A
Composite endpoint of 90-day all-cause mortality and/or 24-hour post-procedure sICH (ITT, n = 139).
STUDY B
Superior clinical outcomes (mRS ≤ 2 at 90 days) in the CLEAR study versus with predicate studies (mITT, n = 107).
Maximized retention, Maximized reperfusion
SIGNIFICANTLY BETTER AT PREVENTING CLOT FRAGMENTS FROM EMBOLIZING DISTAL TERRITORIES*
*Results from randomized, in-vitro simulated thrombectomy studies: Vania et al. JVIN, Feb 2023, Li et al. JNIS, May 2023.
CLOT FRAGMENTS GENERATED*
*Results from randomized, in-vitro simulated thrombectomy studies: Vania et al. JVIN, Feb 2023.
FREQUENCY OF LARGE EMBOLI GENERATED*
*Results from randomized, in-vitro simulated thrombectomy studies: Li et al. JNIS, May 2023.
28% LESS
FRAGMENTS > 1mm generated versus Solitaire
P=0.003
24% LESS
FRAGMENTS > 1mm generated versus Embotrap 2.
P=0.003
TOTAL AREA OF EMBOLI GENERATED*
*Results from randomized, in-vitro simulated thrombectomy studies: 6. Li et al. JNIS, May 2023.
The structure in detail
Product Number
30020V-MS
VN-4529-03RR
VN-5537-03RR
VN-5537-03NR
Description
NeVa 4.0 x 22 mm
NeVa 4.5 x 29 mm
NeVa 5.5 x 37 mm
NeVa NET 5.5 x 37 mm
Diameter (mm)
4.0
4.5
5.5
5.5
Working Lemgth (mm)
22
29
37
37
39
46
56
56
Push-wire Length (mm)
180
180
180
180
Number of Drop Zones
2
3
3
3
Minimum MC ID (Inches)
.021″
.021″
.027″
.027″
